Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Medical Management
100%
Peripheral Arterial Disease
100%
Therapeutic Algorithm
100%
Symptomatic Patients
80%
Risk Reduction
40%
Intermittent Claudication
40%
Coronary Artery Disease
20%
Cardiovascular Morbidity
20%
Moderate to Severe
20%
Smoking Cessation
20%
Atherosclerotic Risk Factors
20%
Common Symptoms
20%
Functional Capacity
20%
Statins
20%
Antithrombotic Strategies
20%
Beta-blockers
20%
High Prevalence
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
Functional Status
20%
Antiplatelet Therapy
20%
Appropriate Treatment
20%
Pentoxifylline
20%
Cardiovascular Mortality
20%
Associated Morbidity
20%
Treatment Goals
20%
Limb Loss
20%
Cilostazol
20%
Systemic Atherosclerosis
20%
Homocysteine Levels
20%
Exercise Program
20%
Exercise Promotion
20%
Nursing and Health Professions
Peripheral Occlusive Artery Disease
100%
Disease Management
100%
Functional Status
40%
Intermittent Claudication
40%
Nicotine Withdrawal
20%
Prevalence
20%
Diseases
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Atherosclerosis
20%
Coronary Artery Disease
20%
Anticoagulant Agent
20%
Palliative Therapy
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Pentoxifylline
20%
Homocysteine
20%
Beta Adrenergic Receptor Blocking Agent
20%
Cilostazol
20%
Medicine and Dentistry
Arteriosclerosis Obliterans
100%
Functional Status
40%
Risk Reduction
40%
Intermittent Claudication
40%
Diseases
20%
Cardiovascular System
20%
Coronary Artery Disease
20%
Nicotine Withdrawal
20%
Atherosclerosis
20%
Prevalence
20%
Limb
20%
Statin
20%
Antiplatelet
20%
Symptomatic Treatment
20%
Antithrombotic Therapy
20%
ACE Inhibitor
20%
Beta Adrenergic Receptor Blocking Agent
20%
Homocysteine
20%
Pentoxifylline
20%
Cilostazol
20%
Pharmacology, Toxicology and Pharmaceutical Science
Peripheral Occlusive Artery Disease
100%
Functional Status
40%
Intermittent Claudication
40%
Diseases
20%
Atherosclerosis
20%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Coronary Artery Disease
20%
Antiplatelet
20%
Prevalence
20%
Dipeptidyl Carboxypeptidase Inhibitor
20%
Beta Adrenergic Receptor Blocking Agent
20%
Antithrombotic Therapy
20%
Homocysteine
20%
Cilostazol
20%
Pentoxifylline
20%